Insiders · Profile

Oosthuizen Johannes Jacobus

President, U.S. Market at Merck. Filing since 28 Oct 2022. CIK 0001916310

Company
Date
Role
Action
Shares
Amount
Of holding
6 Feb 2026
President, U.S. Market
Sold at will
15,000
$1.83M
41.4%
19 Feb 2025
President, U.S. Market
Sold at will
8,500
$714.74K
21.7%
2 Feb 2024
President, U.S. Market
Sold at will
18,959
$2.41M
44.8%
9 Nov 2023
President, U.S. Market
Sold at will
2,081
$213.06K
10.3%
9 Nov 2022
President, U.S. Market
Sold, plan not stated
1,795
$185.26K
9.7%
7 Nov 2022
President, U.S. Market
Sold, plan not stated
45,561
$4.53M
71.1%
28 Oct 2022
President, U.S. Market
Sold, plan not stated
3,633
$364.06K
25.0%
7 decisions on file.